⌕
RXO · RXO · NYSE
Tenet 32 · Weak
Compare
$28.35−0.25%At closeTenet 32 · Weak
$28.35−0.07 (−0.25%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD

RXO News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● MarketBeatNov 13, 2026 · 20:12 ET
C.H. Robinson Worldwide Targets $300 Million in RXO Savings as Freight Costs Rise

C.H. Robinson Worldwide NASDAQ: CHRW executives said the freight broker plans to continue investing in organic growth while pursuing its RXO acquisition, with Chief Financial Officer Damon Lee pointing to anticipated cos…

● GlobeNewsWireNov 11, 2026 · 11:05 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)

BALA CYNWYD, Pa., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

● GlobeNewsWireNov 4, 2026 · 08:14 ET
INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger – OPCH, PTC, RXO and SYNA - IS IT A FAIR DEAL FOR YOU?

NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney  Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a …

● PRNewsWireNov 3, 2026 · 19:06 ET
Are OPCH, PTC, RXO Obtaining Fair Deals for their Shareholders?

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws…

● GlobeNewsWireOct 30, 2026 · 09:36 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: ADT Inc. (NYSE – ADT), RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR)

BALA CYNWYD, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

● Zacks Investment ResearchOct 29, 2026 · 10:31 ETEARNINGS EXPECTED BY FEB 8
RXO (RXO) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago ac…

● Zacks Investment ResearchOct 29, 2026 · 08:46 ETEARNINGS EXPECTED BY FEB 8
RXO (RXO) Q3 Earnings and Revenues Top Estimates

RXO (RXO) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.01 per share a year ago.…

● Business WireOct 29, 2026 · 06:30 ETCOMPANY'S OWN WORDSEARNINGS EXPECTED BY FEB 8
RXO Delivers Strong Third-Quarter Results with Profitable Growth and Continued Market Share Gains

CHARLOTTE, N.C.--(BUSINESS WIRE)---- $RXO #nyse--RXO (NYSE: RXO) today reported strong third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, “We exceeded the high end of our third-quarter profit outl…

● Zacks Investment ResearchOct 22, 2026 · 09:56 ET
Despite Fast-paced Momentum, RXO (RXO) Is Still a Bargain Stock

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, RXO (RXO) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced M…

● GuruFocusOct 20, 2026 · 13:00 ET
Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?

Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 20, 2026Insiders may stand to receive substantial financial benef…

● GlobeNewsWireOct 20, 2026 · 08:03 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)

BALA CYNWYD, Pa., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

● GuruFocusOct 12, 2026 · 21:00 ET
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?

Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?PR NewswireNEW YORK, Oct. 12, 2026Insiders may stand to receive substantial financial bene…

● MarketBeatOct 12, 2026 · 09:45 ET
C.H. Robinson Bets Its AI Story on RXO—But the Market Isn't Sold

Investors in C.H. Robinson Worldwide NASDAQ: CHRW have had a few days to react to the company's announcement of a stock-and-cash agreement to acquire RXO NYSE: RXO with an implied value of $5.8 billion.…

● PRNewsWireOct 6, 2026 · 15:28 ET
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of RXO, Inc. (NYSE: RXO)

NEW YORK, Oct. 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 5…

● Zacks Investment ResearchOct 6, 2026 · 15:11 ET
C.H. Robinson to Benefit From RXO Acquisition: Here's How

CHRW's $5.8B RXO acquisition is set to expand its logistics network, boost AI capabilities and deliver $300M in cost synergies.…

● Business WireOct 6, 2026 · 13:12 ET
RXO Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of RXO Inc. - RXO

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of RXO Inc. (NYSE: RXO)…

● Zacks Investment ResearchOct 6, 2026 · 09:56 ET
RXO (RXO) Is Attractively Priced Despite Fast-paced Momentum

RXO (RXO) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-P…

● Defense WorldOct 6, 2026 · 08:07 ET
RXO (NYSE:RXO) Stock Rating Cut to “Hold” at Jefferies Financial Group

RXO (NYSE: RXO - Get Free Report) was downgraded by equities researchers at Jefferies Financial Group from a "buy" rating to a "hold" rating in a research note issued on Tuesday, Marketbeat Ratings reports. They currentl…

● WSJOct 6, 2026 · 07:12 ET
Freight Broker C.H. Robinson to Buy Smaller Rival RXO

Plus, the U.S. will temporarily allow highway sales of dyed diesel, and Persian Gulf oil producers pay millions to move crude.…

● GlobeNewsWireOct 5, 2026 · 15:01 ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RXO Inc. (NYSE – RXO), PTC Inc. (Nasdaq – PTC), Lifecore Biomedical, Inc. (Nasdaq – LFCR), WaFd, Inc. (Nasdaq – WAFD)

BALA CYNWYD, Pa., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith…

● Business WireOct 5, 2026 · 13:13 ET
RXO Stock Alert: Halper Sadeh LLC is Investigating Whether RXO Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of RXO Inc. (NYSE: RXO) to C.H. Robinson Worldwide, Inc. for $17.25 per share in cash and 0.0856 shares of C.H. Robinson…

● PRNewsWireOct 5, 2026 · 11:59 ET
RXO SHAREHOLDER ALERT: ADEMI LLP INVESTIGATES WHETHER BUYOUT FAIRLY VALUES RXO INC.

RXO shareholders will receive just $17.25 per share in cash and 0.0856 shares of C.H. Robinson Worldwide common stock for each RXO share, representing an implied total consideration of $30.25 per share in a transaction v…

Kept in their own lane. A press release is the company talking, not reporting.

Expected by Feb 8. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.

Article counts from the last market-wide feed page, across every symbol we track and not just RXO · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.